MOLN
Molecular Partners AG ADR
NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY
$4.23
-4.94% today
Updated 2026-04-30
Market cap
$162.74M
P/E ratio
—
P/S ratio
158.42x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$3 – $5
Volume
0.0M
Molecular Partners AG ADR (MOLN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |